A detailed history of Black Rock Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,446,366 shares of REGN stock, worth $6.03 Billion. This represents 0.2% of its overall portfolio holdings.

Number of Shares
8,446,366
Previous 8,568,654 1.43%
Holding current value
$6.03 Billion
Previous $8.25 Billion 7.64%
% of portfolio
0.2%
Previous 0.19%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$883.2 - $1071.19 $108 Million - $131 Million
-122,288 Reduced 1.43%
8,446,366 $8.88 Billion
Q1 2024

May 10, 2024

SELL
$902.69 - $993.35 $55.1 Million - $60.6 Million
-61,053 Reduced 0.71%
8,568,654 $8.25 Billion
Q4 2023

Feb 13, 2024

SELL
$775.18 - $881.7 $190 Million - $217 Million
-245,602 Reduced 2.77%
8,629,707 $7.58 Billion
Q3 2023

Nov 13, 2023

SELL
$692.45 - $844.37 $146 Million - $178 Million
-210,673 Reduced 2.32%
8,875,309 $7.3 Billion
Q2 2023

Aug 11, 2023

SELL
$700.03 - $830.35 $233 Million - $276 Million
-332,318 Reduced 3.53%
9,085,982 $6.53 Billion
Q1 2023

May 12, 2023

BUY
$680.49 - $826.97 $171 Million - $208 Million
251,483 Added 2.74%
9,418,300 $7.74 Billion
Q4 2022

Feb 13, 2023

SELL
$705.89 - $766.39 $226 Million - $246 Million
-320,426 Reduced 3.38%
9,166,817 $6.61 Billion
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $486,152 - $613,499
-847 Reduced 0.01%
9,487,243 $6.54 Billion
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $53.1 Million - $71.6 Million
-96,861 Reduced 1.01%
9,488,090 $5.61 Billion
Q1 2022

May 12, 2022

SELL
$595.12 - $698.43 $15.4 Million - $18.1 Million
-25,920 Reduced 0.27%
9,584,951 $6.69 Billion
Q4 2021

Feb 10, 2022

BUY
$543.48 - $670.97 $133 Million - $164 Million
244,009 Added 2.61%
9,610,871 $6.07 Billion
Q3 2021

Nov 09, 2021

BUY
$574.03 - $680.96 $191 Million - $227 Million
333,312 Added 3.69%
9,366,862 $5.67 Billion
Q2 2021

Aug 11, 2021

BUY
$472.8 - $558.54 $4.27 Billion - $5.05 Billion
9,033,550 New
9,033,550 $5.05 Billion

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.